Clinical Trial Update: Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma [NA]

View source ↗

Summary

Clinical trial evaluating induction chemotherapy with ABVD followed by brentuximab vedotin consolidation in newly diagnosed, non-bulky stage I/II Hodgkin lympho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• ABVD
• Brentuximab vedotin (Brentuximab vedotin)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Hodgkin Lymphoma, Adult | NA | Status: COMPLETED | Results posted: 2017-10-12